The investment company specializing in biotechnology and health, and a member of CataloniaBio & HealthTech, Capital  Cell, has raised 14 million euros. They are higher figures than the 13.5 million it raised throughout the 2020 financial year.

The director of the company, Daniel Oliver, sets the goal of reaching 16 million by the end of the current year. With this growth, Capital Cell could once again be the leader in crowdfunding in Spain in 2021.

Capital Cell was founded in 2015 as the first online investment platform in Europe specializing in biotechnology and health. Among the successes of the last almost two years, they have also helped finance CataloniaBio & HealthTech members such as Methinks, Cornea Project, Ability Pharma and Aortyx, among others.